{
  "respiratory": {
    "active_patents": [
      {"patent_number": "US12345678", "title": "Novel bronchodilator formulation", "expiry": "2028-05-15"},
      {"patent_number": "US87654321", "title": "Inhalation device for asthma", "expiry": "2029-11-20"}
    ],
    "patent_expiry_timeline": [
      {"patent_number": "US11111111", "expiry_date": "2026-03-10", "molecule": "Albuterol"},
      {"patent_number": "US22222222", "expiry_date": "2027-08-25", "molecule": "Salmeterol"}
    ],
    "freedom_to_operate": "restricted",
    "fto_risks": ["US12345678", "US87654321"],
    "innovation_trends": ["Combination therapies", "Extended-release formulations"],
    "key_patents": ["US12345678", "US87654321"],
    "competitive_filings": {
      "2024": 45,
      "2023": 38,
      "2022": 32
    }
  },
  "metformin": {
    "active_patents": [],
    "patent_expiry_timeline": [
      {"patent_number": "US33333333", "expiry_date": "2020-01-01", "molecule": "Metformin", "status": "expired"}
    ],
    "freedom_to_operate": "clear",
    "fto_risks": [],
    "innovation_trends": ["Extended-release", "Combination products"],
    "key_patents": [],
    "competitive_filings": {
      "2024": 12,
      "2023": 15,
      "2022": 18
    }
  },
  "statin": {
    "active_patents": [
      {"patent_number": "US44444444", "title": "Atorvastatin formulation", "expiry": "2025-12-31"},
      {"patent_number": "US55555555", "title": "Rosuvastatin combination", "expiry": "2026-06-30"}
    ],
    "patent_expiry_timeline": [
      {"patent_number": "US44444444", "expiry_date": "2025-12-31", "molecule": "Atorvastatin"},
      {"patent_number": "US55555555", "expiry_date": "2026-06-30", "molecule": "Rosuvastatin"}
    ],
    "freedom_to_operate": "restricted",
    "fto_risks": ["US44444444"],
    "innovation_trends": ["Fixed-dose combinations", "Novel delivery systems"],
    "key_patents": ["US44444444", "US55555555"]
  }
}

